Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Georgia Endoscopy Center (Colonoscopy only)
mi
from
Alpharetta, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Georgia Endoscopy Center (Colonoscopy only)
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
GI Consultants (Colonoscopy only)
mi
from
Atlanta, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
GI Consultants (Colonoscopy only)
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Emory Healthcare Heart Center (EKG)
mi
from
Johns Creek, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Emory Healthcare Heart Center (EKG)
mi
from
Johns Creek, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Atlanta Gastroenterology Specialists, PC
mi
from
Suwanee, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Atlanta Gastroenterology Specialists, PC
mi
from
Suwanee, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Johns Creek Diagnostic Center (X-Ray only)
mi
from
Suwanee, GA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Johns Creek Diagnostic Center (X-Ray only)
mi
from
Suwanee, GA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Southwest Gastroenterology
mi
from
Oak Lawn, IL
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Southwest Gastroenterology
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Huron Gastroenterology Associates / Center for Digestive Care
mi
from
Ypsilanti, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Huron Gastroenterology Associates / Center for Digestive Care
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
St. Joseph Mercy Health System Clinical Lab
mi
from
Ypsilanti, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
St. Joseph Mercy Health System Clinical Lab
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Center for Advanced Medicine
mi
from
Saint Louis, MO
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Center for Advanced Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Washington University School of Medicine - Division of Gastroenterology
mi
from
Saint Louis, MO
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Washington University School of Medicine - Division of Gastroenterology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Sunrise Medical Labs
mi
from
Hicksville, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Sunrise Medical Labs
mi
from
Hicksville, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Columbia University Medical Center
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Kornbluth, Legnani, George MD, PC
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Kornbluth, Legnani, George MD, PC
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Mount Sinai Doctos Faculty Practice
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Mount Sinai Doctos Faculty Practice
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Clevland Clinic Department of Pharmacy
mi
from
Cleveland, OH
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Clevland Clinic Department of Pharmacy
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Great Lakes Gastroenterology
mi
from
Mentor, OH
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Baylor Medical Center
mi
from
Houston, TX
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Baylor Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Gastroenterology Consultants
mi
from
Houston, TX
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Gastroenterology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Houston Hospital for Specialized Surgery
mi
from
Houston, TX
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Houston Hospital for Specialized Surgery
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Wasatch Clinical Research
mi
from
Salt Lake City, UT
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Center for Digestive Health
mi
from
Milwaukee, WI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Center for Digestive Health
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Cedars Sinai Medical Center - Thalians Bldg
mi
from
Los Angeles, CA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Cedars Sinai Medical Center - Thalians Bldg
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Sharp Rees-Stealy
mi
from
San Diego, CA
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Sharp Rees-Stealy
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Florida Surgery Center
mi
from
Altamonte Springs, FL
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Florida Surgery Center
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Sand Lake Imaging
mi
from
Maitland, FL
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Sand Lake Imaging
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Florida Medical Clinic
mi
from
Zephyrhills, FL
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Saint Joseph Mercy Hospital - Inpatient Pharmacy (Pharmacy Only)
mi
from
Ann Arbor, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Saint Joseph Mercy Hospital - Inpatient Pharmacy (Pharmacy Only)
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
East Ann Arbor Health and Geriatrics Center - University of Michigan Health Systems
mi
from
Ann Arbor, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
East Ann Arbor Health and Geriatrics Center - University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Michigan Clinical Research Unit - Univeristy of Michigan Health System
mi
from
Ann Arbor, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Michigan Clinical Research Unit - Univeristy of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Medical Science Research Building 1 - University of Michigan Health Systems
mi
from
Ann Arbor, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Medical Science Research Building 1 - University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Michigan Heart SJMH
mi
from
Ypsilanti, MI
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Michigan Heart SJMH
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
The Private Practice of Simon Lichtiger, MD
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
The Private Practice of Simon Lichtiger, MD
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
CUMC Research Pharmacy
mi
from
New York, NY
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
CUMC Research Pharmacy
mi
from
New York, NY
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Baylor College of Medicine - Baylor Medical Center (Drug Storage)
mi
from
Houston, TX
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Baylor College of Medicine - Baylor Medical Center (Drug Storage)
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/24/2015
Royal Prince Alfred Hospital
mi
from
Camperdown,
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/24/2015
Royal Prince Alfred Hospital
mi
from
Camperdown,
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Advanced Medical Research Center
mi
from
Port Orange, FL
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Advanced Medical Research Center
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Florida Medical Clinic-Tampa Clinic
mi
from
Tampa, FL
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Florida Medical Clinic-Tampa Clinic
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Washington University School of Medicine
mi
from
St. Louis, MO
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Mount Sinai School of Medicine
mi
from
New York, NY
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
Dayton Science Institute
mi
from
Dayton, OH
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
Dayton Science Institute
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated:  9/23/2015
mi
from
Abbotsford,
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Status: Enrolling
Updated: 9/23/2015
mi
from
Abbotsford,
Click here to add this to my saved trials
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials